CHU-Hôtel Dieu Service de Médecine Nucléaire

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET	digestive system neuroendocrine neoplasm	Active, not recruiting	Phase 3	2026-01-21		NCT03972488

Clinical trials